Home NDC 57955-3721 Allergies Southern U.S.
Product NDC 57955-3721
11-digit product format 579553721
Labeler code 57955
Product ID 57955-3721_59ece124-d644-41a0-bec6-0f748ae6fc69
Type HUMAN OTC DRUG
Nonproprietary name Adenosinum cycloposphorcum, Adrenalinum, Adrenocorticotrophin, Allium cepa, Alnus ser, Arum triph, Arundo, Carduus ben, Cichorium int, Cortisone aceticum, Dolichos, Euphrasia, Galphimia, Histaminum hydrochloricum, Juglans cin, Kali mur, Nasturtium, Nat mur, Rhus tox RNA, Sabaadilla, Sassafras.
Dosage form LIQUID
Route ORAL
Labeler King Bio Inc.
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 2022-04-27
Marketing end 0000-00-00
Substance ADENOSINE CYCLIC PHOSPHATE; ALNUS SERRULATA BARK; ARISAEMA TRIPHYLLUM ROOT; ARUNDO PLINIANA ROOT; CENTAUREA BENEDICTA; CHICORY ROOT; CORTICOTROPIN; CORTISONE ACETATE; EPINEPHRINE; EUPHRASIA STRICTA; GALPHIMIA GLAUCA FLOWERING TOP; HISTAMINE DIHYDROCHLORIDE; JUGLANS CINEREA BRANCH BARK/ROOT BARK; MUCUNA PRURIENS FRUIT TRICHOME; NASTURTIUM OFFICINALE; ONION; POTASSIUM CHLORIDE; SACCHAROMYCES CEREVISIAE RNA; SASSAFRAS ALBIDUM ROOT BARK; SCHOENOCAULON OFFICINALE SEED; SODIUM CHLORIDE; TOXICODENDRON PUBESCENS LEAF
Active strength 12 [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL
Pharmacologic classes Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 4 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 57955-3721-2 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 57955-3721-2 f5e01cc5f278…a2eaf40c39c3…
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 57955-3721-2 57955372102 59 mL in 1 BOTTLE, SPRAY (57955-3721-2) 59 ml 2022-04-27 0000-00-00 No No Current